Acadian Asset Management
BLUE

Acadian Asset Management’s bluebird bio BLUE Stock Holding History

Acadian Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-144
Closed -$60K – 1732
2021
Q2 		$60K Buy
+144
New +$57K ﹤0.01% 1772
2021
Q1 		– Sell
-45
Closed -$25K – 2069
2020
Q4 		$25K Sell
45
-74
-62% -$46.9K ﹤0.01% 2109
2020
Q3 		$84K Buy
+119
New +$92.8K ﹤0.01% 1712

Other funds holding BLUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Acadian Asset Management's BLUE Position: Q3 2021 in Review

Acadian Asset Management sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 144 shares — an estimated $60K sold.

Acadian Asset Management first reported a position in BLUE in Q3 2020 and held it in 3 quarters. The position peaked at $84K in Q3 2020. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.

  • Acadian Asset Management reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
  • Acadian Asset Management sold 144 bluebird bio shares in Q3 2021, an estimated $60K.
  • Acadian Asset Management first reported a position in bluebird bio in Q3 2020 and held it in 3 quarters.
  • Acadian Asset Management's bluebird bio position peaked at $84K in Q3 2020.
  • 196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.

Based on Acadian Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.